Introduction: Many studies have shown that the progression of Alzheimer’s disease (AD) varies substantially from patient to patient. It is important to identify subpopulations who may benefit from the investigational treatment. Subgroup identification can help clinicians select patients who are most likely to have a positive response to a treatment. It may also inform the […]
23. Subgroup Identification Based on Mixed Model for Repeated Measures for Alzheimer Disease Trial
